Nifty

:

26202.95

Sensex

:

85706.67

-12.60 (-0.05%)
-13.71 (-0.02%)

Login

Nifty
Sensex

:
:

26202.95
85706.67

-12.60 (-0.05%)
-13.71 (-0.02%)

Cohance Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

37/99

BSE: 543064 | NSE: COHANCE

Watchlist

NSE BSE

564.40

28-Nov-2025

Open
High
Low
Previous Close

571.25
574.5
562.6
574.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

280882
158691237.6
1360
556.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

21,590.18
87.11
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

21,714.33
N/A
5.70

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
3.47
-3.68

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-3.27
-8.16

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-2.79
-13.32

P:E (Median)

8 Years
5 Years
3 Years

-
36.37
52.79

P:BV (Average)

8 Years
5 Years
3 Years

-
11.02
11.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
38.59
47.69

Earnings Forecasts:

(Updated: 22-11-2025)

Description 2024 2025 2026 2027
Adj EPS 10.52 12.13 16.95 21.45
P/E Ratio 53.65 46.53 33.30 26.31
Revenue 1172.28 2526.45 3215.84 3771.24
EBITDA 375.2 708.31 928.31 1181.77
Net Income 267.87 454.75 605.04 786.71
ROA 10.13 16.01 18.41 26.07
P/B Ratio 8.47 5.94 5.13 4.31
ROE 14.3 12.8 15.62 17.38
FCFF 129.05 227.87 242.2 1205.78
FCFF Yield 0.58 1.02 1.08 5.38
Net Debt -1.34 -268.73 -221.1 -390.87
BVPS 66.64 95 110.07 131.01

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 497.79 594.43 -16.26% 483.58 488.08 -0.92% 330.17 252.93 30.54% 275.39 212.82 29.40%
Expenses 366.93 390.91 -6.13% 379.38 362.91 4.54% 262.99 179.60 46.43% 159.93 143.76 11.25%
EBITDA 130.86 203.52 -35.70% 104.20 125.17 -16.75% 67.18 73.33 -8.39% 115.46 69.06 67.19%
EBIDTM 26.29% 34.24% 21.55% 25.65% 20.35% 28.99% 41.93% 32.45%
Other Income 26.30 15.76 66.88% 13.10 19.41 -32.51% 6.63 17.06 -61.14% 15.18 13.97 8.66%
Interest 5.24 9.42 -44.37% 6.80 10.20 -33.33% 2.30 2.30 0.00% 2.60 2.15 20.93%
Depreciation 31.20 34.56 -9.72% 31.36 31.28 0.26% 15.19 17.25 -11.94% 13.44 11.38 18.10%
PBT 120.72 175.30 -31.14% 71.04 103.10 -31.10% 56.32 70.84 -20.50% 114.60 69.50 64.89%
Tax 26.43 36.20 -26.99% 18.47 27.65 -33.20% 11.98 17.62 -32.01% 28.25 17.14 64.82%
PAT 94.29 139.10 -32.21% 52.57 75.45 -30.32% 44.34 53.22 -16.69% 86.35 52.36 64.92%
PATM 18.94% 23.40% 10.87% 15.46% 13.43% 21.04% 31.36% 24.60%
EPS 2.46 3.64 -32.42% 1.37 1.97 -30.46% 1.16 1.39 -16.55% 2.26 1.37 64.96%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 555.57 603.77 -7.98% 549.31 488.08 12.55% 402.02 252.93 58.95% 307.15 219.82 39.73%
Expenses 434.62 398.40 9.09% 437.30 362.98 20.47% 328.46 179.59 82.89% 189.45 153.74 23.23%
EBITDA 120.95 205.37 -41.11% 112.01 125.10 -10.46% 73.56 73.34 0.30% 117.70 66.08 78.12%
EBIDTM 21.77% 34.01% 20.39% 25.63% 18.30% 29.00% 38.32% 30.06%
Other Income 15.60 16.19 -3.64% 14.17 19.41 -27.00% 10.57 17.06 -38.04% 15.71 14.34 9.55%
Interest 8.76 9.61 -8.84% 10.18 10.20 -0.20% 5.75 2.30 150.00% 3.33 2.16 54.17%
Depreciation 44.02 37.79 16.49% 45.14 31.28 44.31% 26.78 17.25 55.25% 20.35 12.79 59.11%
PBT 83.77 174.16 -51.90% 62.76 103.03 -39.09% 51.60 70.85 -27.17% 109.73 65.47 67.60%
Tax 17.38 35.92 -51.61% 16.36 27.66 -40.85% 12.87 17.48 -26.37% 26.44 18.72 41.24%
PAT 66.39 138.24 -51.97% 46.40 75.37 -38.44% 38.73 53.37 -27.43% 83.29 46.75 78.16%
PATM 11.95% 22.90% 8.45% 15.44% 9.63% 21.10% 27.12% 21.27%
EPS 1.94 5.44 -64.34% 1.28 2.96 -56.76% 1.65 2.10 -21.43% 3.26 1.84 77.17%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,586.93 1,093.51 1,051.35 1,330.08 1,320.22 1,009.72 833.79 377.83 Net Sales Growth 2.50% 4.01% -20.96% 0.75% 30.75% 21.10% 120.68% Cost Of Goods Sold 462.14 294.49 311.39 394.26 394.05 297.56 225.32 101.46 Gross Profit 1,124.79 799.02 739.96 935.83 926.17 712.16 608.47 276.37 GP Margin 70.88% 73.07% 70.38% 70.36% 70.15% 70.53% 72.98% 73.15% Total Expenditure 1,169.23 730.94 645.49 739.39 737.94 566.68 449.00 206.28 Power & Fuel Cost - 42.19 48.30 71.35 59.55 44.20 38.23 18.06 % Of Sales - 3.86% 4.59% 5.36% 4.51% 4.38% 4.59% 4.78% Employee Cost - 198.30 135.23 108.58 100.48 76.23 65.10 29.63 % Of Sales - 18.13% 12.86% 8.16% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 86.00 88.85 106.75 129.24 105.31 83.89 35.11 % Of Sales - 7.86% 8.45% 8.03% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 35.67 27.05 31.13 28.43 27.69 25.93 12.62 % Of Sales - 3.26% 2.57% 2.34% 2.15% 2.74% 3.11% 3.34% Selling & Distn. Exp. - 12.17 10.46 17.43 19.80 10.53 9.43 6.72 % Of Sales - 1.11% 0.99% 1.31% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 62.12 24.21 9.90 6.37 5.16 1.08 2.69 % Of Sales - 5.68% 2.30% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 417.70 362.57 405.86 590.69 582.28 443.04 384.79 171.55 EBITDA Margin 26.32% 33.16% 38.60% 44.41% 44.10% 43.88% 46.15% 45.40% Other Income 61.21 53.98 56.61 44.55 187.79 14.24 18.12 0.60 Interest 16.94 8.00 7.45 12.75 8.53 11.66 21.81 2.79 Depreciation 91.19 57.20 54.60 43.10 39.10 31.64 23.51 11.50 PBT 362.68 351.35 400.42 579.39 722.45 413.98 357.59 157.87 Tax 85.13 79.64 103.95 146.79 164.35 105.33 87.51 48.59 Tax Rate 23.47% 22.67% 25.96% 25.34% 22.75% 25.44% 24.47% 30.78% PAT 277.55 271.71 296.47 432.60 558.10 308.65 270.08 109.27 PAT before Minority Interest 277.55 271.71 296.47 432.60 558.10 308.65 270.08 109.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.49% 24.85% 28.20% 32.52% 42.27% 30.57% 32.39% 28.92% PAT Growth -13.30% -8.35% -31.47% -22.49% 80.82% 14.28% 147.17% EPS 7.25 7.10 7.75 11.31 14.59 8.07 7.06 2.86

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,814.05 1,197.58 1,051.35 1,340.33 1,320.22 1,009.72 833.79 377.83 Net Sales Growth 15.94% 13.91% -21.56% 1.52% 30.75% 21.10% 120.68% Cost Of Goods Sold 478.90 300.73 311.86 402.97 394.05 297.56 225.32 101.46 Gross Profit 1,335.15 896.85 739.49 937.36 926.17 712.16 608.47 276.37 GP Margin 73.60% 74.89% 70.34% 69.94% 70.15% 70.53% 72.98% 73.15% Total Expenditure 1,389.83 822.38 645.54 766.17 738.50 566.72 449.03 206.28 Power & Fuel Cost - 47.29 48.30 73.93 59.55 44.20 38.23 18.06 % Of Sales - 3.95% 4.59% 5.52% 4.51% 4.38% 4.59% 4.78% Employee Cost - 249.56 135.23 118.25 100.48 76.23 65.10 29.63 % Of Sales - 20.84% 12.86% 8.82% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 102.96 88.37 109.62 129.24 105.31 83.89 35.11 % Of Sales - 8.60% 8.41% 8.18% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 45.34 27.11 33.87 28.99 27.73 25.97 12.62 % Of Sales - 3.79% 2.58% 2.53% 2.20% 2.75% 3.11% 3.34% Selling & Distn. Exp. - 14.32 10.46 17.64 19.80 10.53 9.43 6.72 % Of Sales - 1.20% 0.99% 1.32% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 62.18 24.21 9.90 6.37 5.16 1.08 2.69 % Of Sales - 5.19% 2.30% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 424.22 375.20 405.81 574.16 581.72 443.00 384.76 171.55 EBITDA Margin 23.39% 31.33% 38.60% 42.84% 44.06% 43.87% 46.15% 45.40% Other Income 56.05 58.56 61.91 46.36 92.38 14.24 18.12 0.60 Interest 28.02 12.35 7.45 12.81 8.53 11.67 23.07 2.79 Depreciation 136.29 77.49 54.60 47.99 39.10 31.64 23.51 11.50 PBT 307.86 343.92 405.67 559.73 626.48 413.94 356.30 157.87 Tax 73.05 79.15 105.39 148.44 213.78 105.33 87.51 48.59 Tax Rate 23.73% 23.01% 25.98% 26.52% 34.12% 25.45% 24.56% 30.78% PAT 234.81 267.87 300.28 411.29 453.80 308.61 268.79 109.27 PAT before Minority Interest 247.85 264.77 300.28 411.29 453.80 308.61 268.79 109.27 Minority Interest 13.04 3.10 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.94% 22.37% 28.56% 30.69% 34.37% 30.56% 32.24% 28.92% PAT Growth -25.16% -10.79% -26.99% -9.37% 47.05% 14.81% 145.99% EPS 6.14 7.00 7.85 10.75 11.86 8.07 7.03 2.86

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 2,315.55 2,028.35 1,749.38 1,520.69 1,065.18 782.83 590.29 Share Capital 25.46 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 2,273.20 2,000.92 1,723.92 1,495.24 1,039.73 770.10 577.56 Non-Current Liabilities 58.73 68.57 54.77 75.19 73.91 127.68 35.12 Secured Loans 0.00 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 0.00 0.00 7.87 8.89 6.65 8.31 5.95 Current Liabilities 213.53 117.15 298.50 346.23 321.49 319.85 190.67 Trade Payables 71.03 42.25 66.89 105.90 82.93 71.06 53.57 Other Current Liabilities 56.19 21.28 18.53 28.25 28.56 27.51 19.47 Short Term Borrowings 70.00 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 16.31 15.04 148.48 144.94 104.36 127.24 34.83 Total Liabilities 2,587.81 2,214.07 2,102.65 1,942.11 1,460.58 1,230.36 816.08 Net Block 684.79 669.62 512.03 534.19 441.16 356.74 270.90 Gross Block 996.62 928.90 713.00 693.81 569.62 456.66 347.41 Accumulated Depreciation 311.83 259.28 200.98 159.62 128.46 99.91 76.51 Non Current Assets 1,879.05 989.84 1,003.21 695.93 794.13 719.36 393.28 Capital Work in Progress 253.93 179.08 164.81 29.99 96.32 101.71 111.07 Non Current Investment 924.64 118.67 317.21 118.67 245.65 245.65 0.07 Long Term Loans & Adv. 15.69 22.47 9.16 13.07 10.85 15.06 11.02 Other Non Current Assets 0.00 0.00 0.00 0.00 0.16 0.20 0.22 Current Assets 708.76 1,224.23 1,099.44 1,246.19 666.45 511.00 422.80 Current Investments 191.56 773.90 392.85 481.22 180.59 30.67 7.06 Inventories 154.12 231.20 311.47 283.42 201.08 174.87 157.10 Sundry Debtors 242.47 133.66 109.66 236.37 102.38 117.20 147.50 Cash & Bank 22.62 21.73 46.23 32.95 9.56 13.96 12.90 Other Current Assets 97.99 11.90 10.73 9.15 172.83 174.30 98.24 Short Term Loans & Adv. 87.57 51.84 228.50 203.08 116.80 134.56 37.32 Net Current Assets 495.23 1,107.08 800.94 899.96 344.96 191.15 232.13 Total Assets 2,587.81 2,214.07 2,102.65 1,942.12 1,460.58 1,230.36 816.08

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 1,696.58 2,050.67 1,735.18 1,527.18 1,180.81 844.76 590.29 Share Capital 25.46 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 1,654.23 2,023.24 1,709.73 1,501.72 1,155.35 832.03 577.56 Non-Current Liabilities 825.37 86.03 71.79 92.11 73.91 127.68 35.12 Secured Loans 6.24 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 0.26 0.00 8.30 8.89 6.65 8.31 5.95 Current Liabilities 365.19 117.40 303.09 347.52 321.51 319.85 190.67 Trade Payables 80.21 42.35 70.09 105.90 82.93 71.06 53.57 Other Current Liabilities 196.01 21.23 19.84 29.54 28.57 27.51 19.47 Short Term Borrowings 70.00 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 18.97 15.24 148.56 144.94 104.36 127.24 34.83 Total Liabilities 3,031.20 2,254.10 2,110.06 1,966.81 1,576.23 1,292.29 816.08 Net Block 1,713.42 669.62 663.33 534.19 441.16 356.74 270.90 Gross Block 2,045.63 929.16 875.60 693.81 569.62 456.66 347.41 Accumulated Depreciation 332.21 259.54 212.27 159.62 128.46 99.91 76.51 Non Current Assets 2,142.61 1,000.89 954.70 701.66 909.68 781.17 393.28 Capital Work in Progress 255.61 179.08 165.09 29.99 96.32 101.71 111.07 Non Current Investment 144.95 130.58 117.10 117.10 361.19 307.46 0.07 Long Term Loans & Adv. 24.05 21.61 9.19 13.07 10.85 15.06 11.02 Other Non Current Assets 4.58 0.00 0.00 7.30 0.16 0.20 0.22 Current Assets 853.28 1,253.21 1,155.37 1,265.16 666.54 511.12 422.80 Current Investments 191.74 773.90 418.94 481.22 180.59 30.67 7.06 Inventories 166.57 231.20 312.81 283.42 201.08 174.87 157.10 Sundry Debtors 284.44 133.66 110.94 236.37 102.38 117.20 147.50 Cash & Bank 88.67 50.50 68.01 47.31 9.65 14.07 12.90 Other Current Assets 121.86 11.90 11.46 9.15 172.83 174.30 98.24 Short Term Loans & Adv. 106.60 52.05 233.21 207.69 116.80 134.56 37.32 Net Current Assets 488.09 1,135.81 852.28 917.64 345.04 191.27 232.13 Total Assets 2,995.89 2,254.10 2,110.07 1,966.82 1,576.22 1,292.29 816.08

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 301.03 376.20 492.82 269.89 328.84 358.75 50.40 PBT 351.35 400.42 579.39 722.45 413.98 357.59 157.87 Adjustment 41.23 17.14 35.68 -110.18 36.48 33.35 13.93 Changes in Working Capital -11.17 67.16 23.53 -190.63 -12.19 54.22 -88.33 Cash after chg. in Working capital 381.41 484.72 638.61 421.64 438.27 445.16 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -80.38 -108.52 -145.79 -151.74 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -320.94 -362.40 -236.86 -90.30 -257.66 -366.65 -65.48 Net Fixed Assets -142.57 -230.17 -154.01 -57.86 -107.57 -99.89 Net Investments -223.63 -182.51 -110.17 -173.65 -149.92 -269.19 Others 45.26 50.28 27.32 141.21 -0.17 2.43 Cash from Financing Activity 20.81 -39.99 -243.14 -156.48 -75.66 8.58 25.98 Net Cash Inflow / Outflow 0.90 -26.19 12.81 23.12 -4.49 0.67 10.90 Opening Cash & Equivalents 18.46 44.65 30.21 7.09 11.58 10.90 0.00 Closing Cash & Equivalent 19.36 18.46 43.02 30.21 7.09 11.58 10.90

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 288.16 384.77 457.20 330.00 382.55 406.92 50.40 PBT 343.92 405.67 559.73 667.59 467.67 404.51 157.87 Adjustment 59.82 17.14 37.46 40.63 36.48 34.60 13.93 Changes in Working Capital -32.14 71.91 5.77 -193.97 -12.17 54.21 -88.33 Cash after chg. in Working capital 371.60 494.72 602.96 514.26 491.98 493.33 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -83.44 -109.95 -145.76 -184.26 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -255.30 -362.35 -195.01 -136.14 -311.40 -413.45 -65.48 Net Fixed Assets -142.57 -230.17 -154.01 -57.86 -107.57 -99.89 Net Investments -223.63 -182.51 -110.17 -173.65 -149.92 -269.19 Others 110.90 50.33 69.17 95.37 -53.91 -44.37 Cash from Financing Activity 3.32 -39.99 -241.95 -156.48 -75.66 7.32 25.98 Net Cash Inflow / Outflow 36.18 -17.57 20.24 37.38 -4.51 0.79 10.90 Opening Cash & Equivalents 47.23 64.80 44.56 7.18 11.70 10.90 0.00 Closing Cash & Equivalent 85.40 47.23 64.80 44.56 7.18 11.70 10.90

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 90.29 79.59 68.72 59.74 41.84 30.75 0.00 ROA 11.32% 13.74% 21.39% 32.80% 22.94% 26.40% 13.39% ROE 12.56% 15.70% 26.46% 43.17% 33.40% 39.71% 18.92% ROCE 16.14% 20.99% 34.48% 51.79% 39.15% 46.23% 23.87% Fixed Asset Turnover 1.14 1.28 1.89 2.09 1.97 2.07 1.09 Receivable days 62.77 42.24 47.44 46.80 39.69 57.94 142.49 Inventory Days 64.31 94.20 81.55 66.93 67.95 72.66 151.76 Payable days 70.20 63.97 79.99 87.45 94.44 49.88 86.75 Cash Conversion Cycle 56.88 72.47 49.01 26.27 13.19 80.72 207.50 Total Debt/Equity 0.03 0.02 0.04 0.06 0.13 0.24 0.14 Interest Cover 44.92 54.75 46.45 85.72 36.49 17.39 57.60

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 65.97 80.47 68.16 59.99 46.39 33.18 0.00 ROA 10.02% 13.76% 20.18% 25.62% 21.52% 25.50% 13.39% ROE 14.20% 15.87% 25.21% 33.52% 30.47% 37.80% 18.92% ROCE 18.44% 21.22% 33.41% 45.92% 36.19% 44.55% 23.87% Fixed Asset Turnover 0.81 1.17 1.71 2.09 1.97 2.07 1.09 Receivable days 63.71 42.46 47.25 46.80 39.69 57.94 142.49 Inventory Days 60.62 94.43 81.11 66.93 67.95 72.66 151.76 Payable days 74.38 65.80 79.70 87.45 94.44 49.88 86.75 Cash Conversion Cycle 49.95 71.09 48.66 26.27 13.19 80.72 207.50 Total Debt/Equity 0.05 0.02 0.04 0.06 0.12 0.22 0.14 Interest Cover 28.85 55.45 44.69 79.29 36.48 16.45 57.60

Top Investors:

jasti property and equity holdings private limited

dsp multicap fund

sbi life insurance co. ltd

hdfc large and mid cap fund

axis mutual fund trustee limited a/c axis mutual f

invesco india contra fund

tata aia life insurance company limited a/c group

investor education and protection fund (iepf)

Annual Reports:

News Update:

Cohance Lifesciences - Quarterly Results
13th Nov 2025, 00:00 AM

Read More
USFDA completes cGMP audit at Cohance Lifesciences’ Andhra Pradesh facility
12th Sep 2025, 14:23 PM

The inspection was conducted from September 8, 2025 to September 11, 2025 and concluded with zero Form 483 observations
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback